全文获取类型
收费全文 | 251篇 |
免费 | 7篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 1篇 |
基础医学 | 47篇 |
口腔科学 | 1篇 |
临床医学 | 20篇 |
内科学 | 41篇 |
皮肤病学 | 2篇 |
神经病学 | 6篇 |
特种医学 | 1篇 |
外科学 | 24篇 |
预防医学 | 26篇 |
眼科学 | 1篇 |
药学 | 19篇 |
中国医学 | 1篇 |
肿瘤学 | 66篇 |
出版年
2023年 | 2篇 |
2021年 | 8篇 |
2020年 | 2篇 |
2019年 | 8篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 7篇 |
2015年 | 4篇 |
2014年 | 6篇 |
2013年 | 11篇 |
2012年 | 10篇 |
2011年 | 12篇 |
2010年 | 6篇 |
2009年 | 4篇 |
2008年 | 8篇 |
2007年 | 8篇 |
2006年 | 22篇 |
2005年 | 9篇 |
2004年 | 14篇 |
2003年 | 10篇 |
2002年 | 8篇 |
2001年 | 8篇 |
2000年 | 9篇 |
1999年 | 11篇 |
1997年 | 3篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1994年 | 5篇 |
1992年 | 6篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 2篇 |
1966年 | 2篇 |
排序方式: 共有258条查询结果,搜索用时 15 毫秒
71.
Bartkova J Lukas C Sørensen CS Rajpert-De Meyts E Skakkebaek NE Lukas J Bartek J 《The Journal of pathology》2003,200(2):149-156
72.
73.
74.
Jirina Bartkova Jiri Lukas Michael Strauss Jiri Bartek 《The Journal of pathology》1994,172(3):237-245
Recent evidence from genetic studies suggests that abnormalities of some of the members of the cyclin superfamily may be intimately associated with tumourigenesis, most likely through deregulation of the cell cycle control. In an attempt to elucidate the potential role of cyclin D1 (a gene located within the 11q13 amplicon and a candidate BCL-1, PRAD-1 oncogene) in the pathogenesis of human neoplasias, we have developed and characterized a novel monoclonal antibody specifically recognizing cyclin D1 protein in various assays including immunohistochemistry on frozen and paraffin sections. Using the DCS-6 antibody as a tool, we now show a characteristic cell cycle-dependent variation of the cyclin D1 protein in human cultured cells and report on the first immunohistochemical study of this G1 cyclin in a range of normal human tissues and breast carcinomas. Analysis of normal tissues revealed generally low levels of cyclin D1 protein, mainly restricted to the proliferative zones of some epithelial tissues, and the lack of its expression in several human tissues including lymph nodes, spleen, and tonsils. In contrast, pronounced overexpression/nuclear accumulation of cyclin D1 was found in 37 per cent of cases in a series of 35 primary ductal carcinomas of the breast. We conclude that the DCS-6 antibody provides a potentially useful tool for the establishment of simple methods suitable for verifying any diagnostic and/or prognostic value of this novel marker on large series of histological specimens and opens the way for biochemical, immunocytochemical, and immunohistochemical studies of the role played by cyclin D1 aberrations in human oncogenesis. 相似文献
75.
Bartek Jiri Dhawan Sanjay Thurin Erik Alattar Ali Gulati Sasha Rydenhag Bertil Henriksson Roger Chen Clark C. Jakola Asgeir Store 《Journal of neuro-oncology》2020,147(2):281-295
Journal of Neuro-Oncology - Glioblastoma remains as the most common and aggressive primary adult brain tumor to date. Within the last decade, cancer immunotherapy surfaced as a broadly successful... 相似文献
76.
Tereza Buchtova Zdenek Skrott Katarina Chroma Jiri Rehulka Petr Dzubak Marian Hajduch David Lukac Stefanos Arampatzis Jiri Bartek Martin Mistrik 《Molecular oncology》2022,16(7):1541
Disulfiram (DSF), an established alcohol‐aversion drug, is a candidate for repurposing in cancer treatment. DSF’s antitumor activity is supported by preclinical studies, case reports, and small clinical trials; however, ongoing clinical trials of advanced‐stage cancer patients encounter variable results. Here, we show that one reason for the inconsistent clinical effects of DSF may reflect interference by other drugs. Using a high‐throughput screening and automated microscopy, we identify cannabidiol, an abundant component of the marijuana plant used by cancer patients to mitigate side effects of chemotherapy, as a likely cause of resistance to DSF. Mechanistically, in cancer cells, cannabidiol triggers the expression of metallothioneins providing protective effects by binding heavy metal‐based substances including the bis‐diethyldithiocarbamate‐copper complex (CuET). CuET is the documented anticancer metabolite of DSF, and we show here that the CuET’s anticancer toxicity is effectively neutralized by metallothioneins. Overall, this work highlights an example of undesirable interference between cancer therapy and the concomitant usage of marijuana products. In contrast, we report that insufficiency of metallothioneins sensitizes cancer cells toward CuET, suggesting a potential predictive biomarker for DSF repurposing in oncology. 相似文献
77.
Jirina Bartkova Johanna Tommiska Lenka Oplustilova Kirsimari Aaltonen Anitta Tamminen Tuomas Heikkinen Martin Mistrik Kristiina Aittomki Carl Blomqvist Pivi Heikkil Jiri Lukas Heli Nevanlinna Jiri Bartek 《Molecular oncology》2008,2(4):296-316
The MRE11, RAD50, and NBS1 genes encode proteins of the MRE11–RAD50–NBS1 (MRN) complex critical for proper maintenance of genomic integrity and tumour suppression; however, the extent and impact of their cancer-predisposing defects, and potential clinical value remain to be determined. Here, we report that among a large series of approximately 1000 breast carcinomas, around 3%, 7% and 10% tumours showed aberrantly reduced protein expression for RAD50, MRE11 and NBS1, respectively. Such defects were more frequent among the ER/PR/ERBB2 triple-negative and higher-grade tumours, among familial (especially BRCA1/BRCA2-associated) rather than sporadic cases, and the NBS1 defects correlated with shorter patients’ survival. The BRCA1-associated and ER/PR/ERBB2 triple-negative tumours also showed high incidence of constitutively active DNA damage signalling (γH2AX) and p53 aberrations. Sequencing the RAD50, MRE11 and NBS1 genes of 8 patients from non-BRCA1/2 breast cancer families whose tumours showed concomitant reduction/loss of all three MRN-complex proteins revealed two germline mutations in MRE11: a missense mutation R202G and a truncating mutation R633STOP (R633X). Gene transfer and protein analysis of cell culture models with mutant MRE11 implicated various destabilization patterns among the MRN complex proteins including NBS1, the abundance of which was restored by re-expression of wild-type MRE11. We propose that germline mutations qualify MRE11 as a novel candidate breast cancer susceptibility gene in a subset of non-BRCA1/2 families. Our data have implications for the concept of the DNA damage response as an intrinsic anti-cancer barrier, various components of which become inactivated during cancer progression and also represent the bulk of breast cancer susceptibility genes discovered to date. 相似文献
78.
79.
80.